Feb 28, 2018 13:10 pm UTC| Business
NEW YORK, Feb. 28, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Vericel...
Aria Systems Named to Constellation ShortList™ for Digital Monetization Solutions
Feb 28, 2018 13:08 pm UTC| Business
SAN FRANCISCO, Feb. 28, 2018 -- Aria Systems, the leader in helping enterprises grow subscription- and usage-based revenue, today announced it has been named to the Constellation ShortList™ for Digital Monetization...
Surgical Tables Market to be worth US$1,014.3 Million by 2022 - Transparency Market Research
Feb 28, 2018 13:07 pm UTC| Business
Albany, NY, Feb. 28, 2018 -- In accordance to the report by TMR, the international surgical tables market is expected to rise from a market valuation of US$ 837.1 mn in 2017 and is predicted to be worth around...
Attivo Networks Achieves Record Results in 2017; Closes With 300+ Percent Revenue Growth
Feb 28, 2018 13:05 pm UTC| Business
FREMONT, Calif., Feb. 28, 2018 -- Attivo Networks®, the leader in deception solutions for cybersecurity defense, today announced record-breaking results for 2017 and continued market momentum generated by increasing...
Aeris & TracPlus Team Up to Track Assets on Land, Sea & Air via IoT
Feb 28, 2018 13:05 pm UTC| Business
SAN JOSE, Calif., and DUNEDIN, New Zealand, Feb. 28, 2018 -- Aeris, a technology leader in the Internet of Things (IoT), said today it is collaborating with TracPlus, a global tracking, communication and collaboration...
Feb 28, 2018 13:04 pm UTC| Business
Albany, NY, Feb. 28, 2018 -- After closely monitoring the global molecular diagnostics market, TMR has prophesied it to expand at an 11.6% CAGR during the forecast tenure 2016-2025 to garner an US$18.9 bn by the final...
Catalyst Pharmaceuticals Announces Its Continuing Support for Rare Disease Day 2018
Feb 28, 2018 13:03 pm UTC| Business
CORAL GABLES, Fla., Feb. 28, 2018 -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic...